{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:46:57Z","timestamp":1791812817404,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02416-6","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:48:30Z","timestamp":1784112510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of sRAGE in clinical heterogeneity and inflammation in endometriosis patients undergoing IVF; case-control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Neda","family":"Emami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Moini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2416_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41588-023-01323-z","volume":"55","author":"N Rahmioglu","year":"2023","unstructured":"Rahmioglu N, Mortlock S, Ghiasi M, M\u00f8ller PL, Lilja H. The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions. Nat Genet. 2023;55:423\u201336.","journal-title":"Nat Genet"},{"key":"2416_CR2","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4239\/wjd.v14.i8.1146","volume":"14","author":"S Bansal","year":"2023","unstructured":"Bansal S, Burman A, Tripathi AK. Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes. World J Diabetes. 2023;14:1146\u201362.","journal-title":"World J Diabetes"},{"issue":"2","key":"2416_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15226\/2374-6890\/3\/2\/0014","volume":"3","author":"JJ Zhang","year":"2016","unstructured":"Zhang JJ, Merhi Z. Could advanced glycation end products explain the poor response to controlled ovarian hyperstimulation in obese women? J Endocrinol Diabetes. 2016;3(2):1\u20139. https:\/\/doi.org\/10.15226\/2374-6890\/3\/2\/0014.","journal-title":"J Endocrinol Diabetes"},{"issue":"10","key":"2416_CR4","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1177\/1933719108323445","volume":"15","author":"EY Fujii","year":"2008","unstructured":"Fujii EY, Nakayama M, Nakagawa A. Concentrations of receptor for advanced glycation end products, VEGF, and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis. Reprod Sci. 2008;15(10):1066\u201374. https:\/\/doi.org\/10.1177\/1933719108323445.","journal-title":"Reprod Sci"},{"key":"2416_CR5","doi-asserted-by":"publisher","first-page":"101958","DOI":"10.1016\/j.redox.2021.101958","volume":"42","author":"JD Erusalimsky","year":"2021","unstructured":"Erusalimsky JD. The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes. Redox Biol. 2021;42:101958. https:\/\/doi.org\/10.1016\/j.redox.2021.101958.","journal-title":"Redox Biol"},{"issue":"1","key":"2416_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/humrep\/det383","volume":"29","author":"Z Merhi","year":"2014","unstructured":"Merhi Z. Advanced glycation end products and their relevance in female reproduction. Hum Reprod. 2014;29(1):135\u201345. https:\/\/doi.org\/10.1093\/humrep\/det383.","journal-title":"Hum Reprod"},{"issue":"3 Suppl","key":"2416_CR7","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1016\/j.fertnstert.2013.07.1591","volume":"100","author":"JD Ambroggio","year":"2013","unstructured":"Ambroggio JD, Casson P, Merhi Z. Soluble receptor for advanced glycation end-products (sRAGE): A potential indicator of ovarian response to controlled ovarian hyperstimulation. Fertil Steril. 2013;100(3 Suppl):S136. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.07.1591.","journal-title":"Fertil Steril"},{"issue":"2","key":"2416_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/humrep\/dew293","volume":"32","author":"NP Johnson","year":"2017","unstructured":"Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS. World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2017;32(2):315\u201324.","journal-title":"Hum Reprod"},{"key":"2416_CR9","doi-asserted-by":"publisher","first-page":"8597318","DOI":"10.1155\/2016\/8597318","volume":"2016","author":"P Santulli","year":"2016","unstructured":"Santulli P, Borghese B, Chouzenoux S, et al. Could oxidative stress play a role in endometriosis? Dis Markers. 2016;2016:8597318. https:\/\/doi.org\/10.1155\/2016\/8597318.","journal-title":"Dis Markers"},{"issue":"3","key":"2416_CR10","doi-asserted-by":"publisher","first-page":"hoad033","DOI":"10.1093\/hropen\/hoad033","volume":"2023","author":"GL Wyatt","year":"2023","unstructured":"Wyatt GL, Fernando SM, Powell SG, Hill CJ, Arshad I, Probert C, et al. The role of iron in the pathogenesis of endometriosis: a systematic review. Hum Reprod Open. 2023;2023(3):hoad033. https:\/\/doi.org\/10.1093\/hropen\/hoad033.","journal-title":"Hum Reprod Open"},{"issue":"1","key":"2416_CR11","first-page":"29","volume":"19","author":"N Emami","year":"2025","unstructured":"Emami N, Moini A, Vesali S. Relation of follicular fluid soluble receptor for advanced glycation end-products concentration and anti-Mullerian hormone in polycystic ovary syndrome and non-PCOS women referring to IVF center: Case-control study. Int J Fertil Steril. 2025;19(1):29\u201335.","journal-title":"Int J Fertil Steril"},{"issue":"6","key":"2416_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1476-5381.2012.02077.x","volume":"167","author":"MB Sukkar","year":"2012","unstructured":"Sukkar MB, Ullah MA, Gan WJ, et al. RAGE: a new frontier in chronic airway disease. Br J Pharmacol. 2012;167(6):1161\u201376. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02077.x.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2416_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1055\/s-0033-1359312","volume":"23","author":"K Prasad","year":"2014","unstructured":"Prasad K. Low levels of serum soluble receptor for advanced glycation end products (sRAGE) are associated with increased risk of inflammatory diseases. Int J Angiol. 2014;23(1):11\u20138. https:\/\/doi.org\/10.1055\/s-0033-1359312.","journal-title":"Int J Angiol"},{"issue":"9","key":"2416_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrrheum.2014.74","volume":"10","author":"AN Burska","year":"2014","unstructured":"Burska AN, Roget K, Blits M, Soto Gomez L, van de Loo F, Hazelwood LD, et al. Gene expression analysis in RA: towards personalized medicine. Nat Rev Rheumatol. 2014;10(9):543\u201352. https:\/\/doi.org\/10.1038\/nrrheum.2014.74.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"2416_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/humupd\/dmq050","volume":"17","author":"P Stratton","year":"2011","unstructured":"Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327\u201346.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"2416_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrendo.2013.255","volume":"10","author":"P Vercellini","year":"2014","unstructured":"Vercellini P, Vigan\u00f2 P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261\u201375.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2416_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/09513590.2017.1409710","volume":"34","author":"T Artimani","year":"2018","unstructured":"Artimani T, Karimi J, Mehdizadeh M, Yavangi M, Khanlarzadeh E, Ghorbani M. Evaluation of pro-inflammatory cytokines (TNF-\u03b1, IL-6) in follicular fluid and serum of women with PCOS. Gynecol Endocrinol. 2018;34(5):435\u20139. https:\/\/doi.org\/10.1080\/09513590.2017.1409710.","journal-title":"Gynecol Endocrinol"},{"key":"2416_CR18","doi-asserted-by":"publisher","first-page":"7265238","DOI":"10.1155\/2017\/7265238","volume":"2017","author":"G Scutiero","year":"2017","unstructured":"Scutiero G, Iannone P, Bernardi G, Bonaccorsi G, Spadaro S, Volta CA, et al. Oxidative stress and endometriosis: a systematic review of the literature. Oxid Med Cell Longev. 2017;2017:7265238. https:\/\/doi.org\/10.1155\/2017\/7265238.","journal-title":"Oxid Med Cell Longev"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02416-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:02:54Z","timestamp":1791810174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02416-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02416-6","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of Tehran university of Medical Science (IR. TUMS.MEDICINE. REC.1403.269) and written informed consent were taken from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki (as revised in 2013). The research protocol was reviewed and approved by the Institutional Ethics Committee of Tehran university of Medical Science (Approval No: IR. TUMS.MEDICINE. REC.1403.269). All participants were fully informed about the study objectives and procedures, and written informed consent was obtained prior to enrollment. Participation was voluntary, and confidentiality of personal and clinical data was strictly maintained throughout the study.","order":3,"name":"Ethics","label":"Helsinki statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"314"}}